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Abstract 
Background: The proportion of individuals who seek treatment for fever is an important quantity in understanding 
access to and use of health systems, as well as for interpreting data on disease incidence from routine surveillance 
systems. For many malaria endemic countries (MECs), treatment-seeking information is available from national house-
hold surveys. The aim of this paper was to assemble sub-national estimates of treatment-seeking behaviours and to 
predict national treatment-seeking measures for all MECs lacking household survey data.
Methods: Data on treatment seeking for fever were obtained from Demographic and Health Surveys, Malaria Indica-
tor Surveys and Multiple Cluster Indicator Surveys for every MEC and year that data were available. National-level 
social, economic and health-related variables were gathered from the World Bank as putative covariates of treatment-
seeking rates. A generalized additive mixed model (GAMM) was used to estimate treatment-seeking behaviours for 
countries where survey data were unavailable. Two separate models were developed to predict the proportion of 
fever cases that would seek treatment at (1) a public health facility or (2) from any kind of treatment provider.
Results: Treatment-seeking data were available for 74 MECs and modelled for the remaining 24. GAMMs found 
that the percentage of pregnant women receiving prenatal care, vaccination rates, education level, government 
health expenditure, and GDP growth were important predictors for both categories of treatment-seeking outcomes. 
Treatment-seeking rates, which varied both within and among regions, revealed that public facilities were not always 
the primary facility type used.
Conclusions: Estimates of treatment-seeking rates show how health services are utilized and help correct reported 
malaria case numbers to obtain more accurate measures of disease burden. The assembled and modelled data dem-
onstrated that while treatment-seeking rates have overall increased over time, access remains low in some malaria 
endemic regions and utilization of government services is in some areas limited.
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Background
Although millions are affected by clinical malaria each 
year, the last 15  years have seen unprecedented gains 
from international efforts made to control this dis-
ease. The establishment of the Roll Back Malaria ini-
tiative and the Millennium Development Goals in the 
year 2000 were followed by a nearly 20-fold increase in 
international funding for malaria control [1]. The scale-
up of interventions that followed has resulted in a 40 % 
decline in Plasmodium falciparum clinical incidence in 
Africa while prevalence of the infection has nearly halved 
since the year 2000 [2]. This and marked reductions in 
malaria-associated deaths [3] were largely attributed to 
increased  coverage of the insecticide-treated bed nets 
(ITNs). Second to ITNs, which were the most widespread 
intervention, access to artemisinin-based combination 
therapy (ACTs) has been found to greatly impact the 
incidence of disease [2].
Open Access
Malaria Journal
*Correspondence:  katherine.battle@zoo.ox.ac.uk 
1 Spatial Ecology and Epidemiology Group, Tinbergen Building, 
Department of Zoology, University of Oxford, South Parks Road, Oxford, 
UK
Full list of author information is available at the end of the article
Page 2 of 11Battle et al. Malar J  (2016) 15:20 
Prompt diagnosis and treatment of clinical malaria is 
the mainstay of all control or elimination programs [4–
6]. The primary aim of treatment with ACT is to curtail 
clinical disease in patients, though access to effective 
treatment also impacts onward transmission to the 
wider community by reducing the infectious reservoir 
while at the same time containing the spread of drug 
resistance [2]. Treatment coverage has been assessed 
across Africa [7], but understanding how access to 
treatment varies throughout the malaria endemic 
world is essential to evaluating the true public health 
impact of treatment coverage. This is all the more sig-
nificant during the current transition from control of 
clinical disease towards regional focuses on malaria 
elimination and the post-2015 future is shaped as pro-
gress towards the Millennium Development Goals is 
evaluated [8].
In assessing care-seeking behaviours, it is also impor-
tant to consider what proportion of care is sought at gov-
ernment-based facilities. Government facilities are more 
likely to comply with recommended diagnostic and treat-
ment schedules [1, 9], and to have their routine records 
integrated into the national health data management 
system. Even in areas with strong surveillance systems, 
reports of passively detected malaria cases will capture 
only a certain fraction of all malaria cases [10–13] and 
so must be adjusted by a number of parameters before 
use as official burden estimates [1, 14]. These include 
(1) treatment-seeking behaviour (representing the pro-
portion of cases not attending health facilities and thus 
being omitted from aggregated case reports [15–22] as 
well as the proportion seeking treatment outside the pub-
lic health system); (2) malaria diagnoses made presump-
tively without parasitological confirmation (leading to 
reported case numbers including non-malaria illnesses 
[23, 24]); and (3) incomplete reporting (which leads to 
cases being lost from reported data) [1, 25]. Here we 
aim to improve the evidence-base of the first parameter 
to enable refined estimates of the true clinical burden of 
malaria disease.
Treatment-seeking rates vary widely between countries 
and greatly affect final burden estimates. Where avail-
able, these parameters are drawn from nationally rep-
resentative, cross-sectional, household surveys such as 
Demographic and Health Surveys (DHS) [26], Malaria 
Indicator Surveys (MIS) [27] and UNICEF Multiple 
Indicator Cluster Surveys (MICS) [28]. However, not all 
malaria-endemic countries (MECs) have such survey 
data available, resulting in these important parameters 
being either assumed or omitted and making compari-
sons of access to treatment across all malaria endemic 
regions and effective estimation of the burden of disease 
difficult.
The aim of this study was an exhaustive assembly of the 
available data on treatment-seeking for all MECs, sub-
nationally where possible. For MECs lacking national 
survey data, predictive models were built to estimate use 
of public facility treatment as well as treatment of any 
kind. These estimates, including measurements of their 
uncertainty, will allow for improved understanding of 
how health services in endemic countries are routinely 
accessed and facilitate more accurate disease burden 
estimation.
Methods
Data assembly
Many DHS, MIS and MICS ask questions to determine 
the prevalence and treatment of fever in children less 
than 5 years of age. Here it was assumed that the treat-
ment-seeking rates observed in children would be similar 
in older age groups, as supported by evidence from India, 
Indonesia and Ethiopia [16, 25]. For a handful of DHS 
surveys (n =  4) and earlier MICS rounds (MICS 3 and 
4, n = 45), data on treatment-seeking for fever were not 
available, so data on treatment-seeking for acute respira-
tory infection (ARI) were used, which have previously 
been shown to correlate strongly with treatment-seeking 
for fever [25]. For surveys that contained treatment-seek-
ing data, the survey codes for questions regarding where 
treatment was sought were reviewed and categorized 
into public/government facilities (likely to have been cap-
tured by reporting systems) or ‘any’ medical treatment, 
which included private or NGO facilities, but excluded 
non-medical categories of care such as homeopathic 
doctors or ‘healers’. To generate a comprehensive data-
base of treatment-seeking information, no time restric-
tion was placed on the year of the survey. However, only 
MICS conducted in the third survey round or later (from 
2005) were included due to inconsistency in interview 
questions on where treatment was sought within earlier 
surveys.
From each survey containing data on fever (or ARI) 
treatment-seeking, the total number of children reported 
to have fever was summarized by cluster and region. The 
numbers seeking treatment at either category of facil-
ity were also totalled to obtain the proportion of those 
who seek public/government facility-based treatment 
or any treatment. These data extractions from the DHS 
and MICS websites [26, 28] and summaries were all 
automated using Feature Manipulation Engine (FME) 
version 2015 by Safe Software [29]. MIS data were 
extracted from the DHS platform and will be discussed 
as part of the DHS survey from here onward. The total 
number of children, fever cases and cases that sought 
treatment were then summarized nationally in order to 
generate predictions for those countries where survey 
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data were unavailable. National survey data require the 
incorporation of sampling weights, which are provided 
in the survey results and help to adjust for differences in 
the probability of selection to produce a more accurate 
representation of population-based metrics. Sampling 
weights were extracted and applied at the individual level 
following DHS guidelines [30], such that the totals and 
proportions reported here were consistent with the same 
metrics (percentage of fever or illness) provided in the 
official survey reports.
Covariate data
Potential covariates were identified for inclusion in a pre-
dictive model using a review of the literature for ‘treat-
ment-seeking’ and ‘care-seeking’ for both ‘malaria’ and 
‘fever’ in PubMed on 18 July 2015 [31]. The following 
have been reported as determinants of care-seeking rates: 
household wealth [15, 17, 19, 20, 22, 32–38], care-giver 
education [15, 19, 32, 34, 39] and household location 
(rural or urban) or access to health facilities [15, 20–22, 
32, 33, 40–45]. The World Bank provides freely available 
national-level indicator data [46], and several indica-
tors that were in keeping with the themes identified by 
the literature were downloaded: access to electricity (as 
a proxy for wealth and access to health facilities), gross 
domestic product (GDP; current US$), GDP per capita, 
GDP growth (annual %), gross national income (GNI) 
per capita (current US$), total health expenditure (% of 
GDP), public health expenditure (% of total), primary 
education completion rate (% of relevant age group), 
and rural population (% of total population). In addi-
tion to these metrics, the number of health workers was 
thought to influence treatment-seeking rates. However, 
there were not sufficient data on the number of commu-
nity health workers per 1000 people available from the 
World Bank, so the number of nurses and midwives per 
1000 population was used instead. Finally, explicit care-
seeking variables were also included: the percentage of 
pregnant women receiving prenatal care and the percent-
age of children aged 12–23 months who were immunized 
against diphtheria, pertussis and tetanus (DPT).
Matching covariate data to national-level survey data 
was also achieved using FME. When available, covari-
ate data were used from the same year as the survey, and 
otherwise were matched to the closest year. Covariate 
data were also matched to those countries without treat-
ment data available. For these countries, covariate data 
was matched to 2013, which was the most recent year 
of indicator data available, or the closest year to that in 
order to generate the most up to date estimates of treat-
ment-seeking rates.
In addition to the social and economic covariate data, 
countries were grouped geographically based on their 
WHO regional offices: Region of the Americas (PAHO), 
Eastern Mediterranean Region (EMRO), European Region 
(EURO), Southeast Asia Region (SEARO), and Western 
Pacific Region (WPRO). Countries in the African region 
were separated into the sub-African regions reported in 
the World Malaria Report: West Africa (AFRO-W), Cen-
tral Africa (AFRO-C), East Africa and high-transmission 
areas in Southern Africa (AFRO-E), and low-transmission 
Southern African countries (AFRO-S) [1]. These regions 
then formed strata within the model, as explained below. 
A map of georeferenced treatment-seeking data availabil-
ity from national surveys in MECs is shown in Fig. 1.
Statistical modelling
Two generalized additive mixed models (GAMMs) were 
developed to predict the proportion of patients that 
sought treatment from (1) a facility covered by the gov-
ernment reporting system, and, (2) any type of medi-
cal care provider [47, 48]. Where multiple surveys were 
used from the same country, this was accounted for by 
adding a country-level random effects term. Both year 
and WHO region were included as fixed effect terms, 
along with the suite of country-level covariates. The list 
of the covariates described above was limited after test-
ing for collinearity among all the potential variables. 
The variables included in GAMMs were: year of survey, 
WHO region, GDP growth, health expenditure, prenatal 
care rates, primary education, DPT immunization rates, 
nurses and midwives per population and proportion 
rural population. All statistical analyses were performed 
in the R statistical computing environment [49]. Full 
details of the model development are provided in Addi-
tional file 1.
Mapping treatment‑seeking
Existing treatment-seeking data were mapped at the 
regional level (boundaries shown in Fig.  1) for the 76 
countries with available survey data. Although some of 
these data were available at a point level, only regional 
maps were generated for consistency with the other 
adjustment parameters. For the few countries with DHS 
cluster data and no regional data available, cluster level 
data were summarized and mapped to the first- (Colom-
bia) or second-level (Zambia) administrative units [50]. 
Predicted and observed values were then combined into 
a single, geographically complete, map of treatment-seek-
ing for all MECs showing the most recent available data 
in each country.
Results
Data assembly
Treatment-seeking data were collected from DHS 
(n  =  195, 13 of which were MIS) and MICS (n  =  59) 
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for 76 countries. The number and year of surveys avail-
able from MECs are shown in Additional file  1: Figure 
S1. Data from DHS and MICS round 5 collected data 
on treatment-seeking for fever, whereas MICS rounds 3 
and 4 assess care-seeking for cough (respiratory infec-
tion). Additional file  1: Figure S2 confirms that rates 
observed from the earlier MICS rounds are comparable 
to the treatment-seeking for subsequent surveys. Indi-
cator data were available for all but nine surveys (there 
was no health expenditure data available for Zimbabwe 
and Somalia); these nine surveys could not therefore be 
included in the analysis. DHS surveys conducted prior to 
1990 were excluded as they reported that no individuals 
sought treatment, and were therefore considered to be 
non-representative. Two MICS surveys, Yemen (2006) 
and Burkina Faso (2006), also reported zero treatment-
seeking and were excluded. The GAMMs were thus fitted 
to 228 records from 72 countries. This left 22 MECs for 
which predictions of treatment-seeking outcomes were 
required. However, Brazil and Paraguay were also added 
to the prediction list since Brazil only had national level 
data available (DHS 1996) and Paraguay had large areas 
of missing data (DHS 1990). This increased the number 
of prediction countries to 24.
Model results
Two models were chosen as the best candidate mod-
els for treatment-seeking from public facilities and five 
for seeking any treatment. The fitted coefficients, AIC, 
ΔAIC and ωi values for each of the best models are 
shown in Table  1. Model average coefficient values for 
each geographic region are shown in Additional file  1: 
Table S1. The parameter with greatest model influence 
was the percentage of pregnant women receiving prena-
tal care, followed by DPT immunization rates for pubic 
treatment-seeking and primary education completion for 
any treatment. Geographic regions were also statistically 
significant, as was public health expenditure. Time was 
also included as an indicator variable because all avail-
able surveys with treatment-seeking information were 
included (1990 and 2005 onwards for DHS and MICS, 
respectively. Plots of observed treatment-seeking rates 
over time (see Additional file 1: Figure S3) confirmed that 
rates of treatment-seeking from any type of facility and 
particularly from government-run facilities increased 
over time. Model validation showed good prediction 
performance (Additional file 1: Figures S4–S6). The root 
mean square error (RMSE) for the percentage seeking 
treatment from government facilities was 11.9 and 12.3 % 
for any treatment facility type.
All observed and predicted values, as well as covari-
ate data, are shown in Additional file 2. There were five 
countries for which insufficient covariate data precluded 
predictions. These countries were therefore assigned 
estimates from a similar and ideally neighbouring coun-
try in the same region (rounded to two decimal places 
to show that they are less precise). Myanmar (Burma) 
was matched to Timor-Leste, which had the most simi-
lar health indicator variables (DPT and pregnant women 
care). In the absence of indicator data or neighbour-
ing countries in the same WHO region the Democratic 
People’s Republic of Korea (DPRK) was given the same 
Fig. 1 Treatment-seeking data in malaria-endemic countries by WHO region. MECs with treatment-seeking data available are shaded yellow and 
those missing data are shown in white. Country borders are coloured based on WHO region: Central Africa (AFRO-C, red), East Africa and high-trans-
mission areas in Southern Africa (AFRO-E, blue), low-transmission Southern African countries (AFRO-S, green) West Africa (AFRO-W, purple), Americas 
(PAHO, brown), Eastern Mediterranean (EMRO, orange), Europe (EURO, yellow), Southeast Asia (SEARO, pink) and Western Pacific (WPRO, grey). Areas 
shaded grey outside the coloured borders have no malaria risk
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estimate as Myanmar (Burma). Eritrea was given the 
same value of neighbouring Ethiopia, French Guiana was 
given Suriname’s values, and the Republic of Korea was 
given China’s estimate, which was closest to Korea for the 
indicators that were available.
The mean predicted values for the proportion seeking 
treatment (government-based or other) in the 24 coun-
tries without survey data available are shown along-
side the post-2010 observed treatment-seeking values 
in Fig.  2. The 95  % CI of the observed measures were 
obtained from the standard error of national weighted 
mean. The predicted measures are shown with black 
points, but are also distinguishable by wider uncertainty 
resulting from the model predictions being made from 
sampling within the confidence intervals of the observed 
measures. In spite of their greater uncertainty, the pre-
dicted point estimates follow the pattern of the observed 
estimates in each region. These plots reveal some areas 
where the proportion of treatment-seeking from gov-
ernment-based facilities is markedly lower, notably in 
SEARO. Greater heterogeneity in estimates of both types 
of treatment-seeking was observed among the countries 
in the African regions.
Despite variability between geographic regions, treat-
ment-seeking rates have generally increased over time. 
The non-linear relationship between treatment-seeking 
and time is shown in Additional file  1: Figure S3. The 
lowest rates of access to government treatment (<10 %) 
were observed prior to the year 2000, with the excep-
tion of findings from DHS surveys from Chad (2004), 
Fig. 2 Predicted and observed treatment-seeking proportions. The predicted proportions estimated for 2013 are shown alongside observed 
values from 2010 onwards for government treatment-seeking (a) and treatment-seeking from any facility (b). Points are coloured by WHO region 
and shown with 95 % CI error bars. Predicted estimates are overlaid with black points. Each point represents a spatial aggregate of a single national 
survey. Countries with multiple points indicate multiple survey types or years
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Bangladesh (2004 and 2007) and Pakistan (2007) and a 
MICS from Somalia in 2006 which were all also <10 %. 
The lowest reported rate of seeking any treatment was 
24  % in Togo in 2006. All observations of treatment-
seeking rates less than 40  % (from any health facility) 
were from the African continent (including Somalia, 
from EMRO). The highest measures of access to pub-
lic facilities (>65  %) were observed in several regions: 
AFRO-C (Nigeria and Sierra Leone), AFRO-E (Zam-
bia and Mozambique), PAHO (Costa Rica, Dominica 
Republic and Peru) and SEARO (Bangladesh (in 2011, 
but not in the earlier years referenced above), Bhutan, 
Indonesia and Timor-Leste). Bhutan had the highest 
reported measure of 74 % of individuals seeking care at 
government-based facilities (MICS 2010). High rates of 
access to any treatment type likewise spanned various 
regions, but values were far greater than public-facility 
data only. Regions with observations of access rates 
to any treatment greater than 80  % include: AFRO-
C (Nigeria), AFRO-E (Tanzania and Uganda), EMRO 
(Pakistan), PAHO (Argentina, Belize, Costa Rica, 
Dominican Republic and Panama), SEARO (Indonesia 
(since 1991) and Thailand) and WPRO (Cambodia and 
Viet Nam).
Regional comparisons of treatment-seeking rates are 
shown in Table  2. Weighted estimates were obtained 
by multiplying the most recent observed or predicted 
value for each of the 98 MECs by the proportion of the 
regional population in each country. Population data 
from 2013 [51] were summarized nationally in ArcGIS 
[52]. While SEARO has lowest overall government-
based treatment-seeking behaviours, this region also 
has the highest access to any treatment. Patterns within 
the other regions were not as marked, but access to 
treatment including facilities outside the formal govern-
ment sector was overall higher.
Mapping treatment‑seeking
The 19 predicted and five assigned national treatment-
seeking estimates were combined with those countries 
that already had data available. Figure  3 shows maps 
for both the proportion seeking government treatment 
(Panel a) and those seeking any treatment (Panel b). Note 
that for both regional comparisons and mapping, priority 
was given to DHS surveys if both a MICS and DHS sur-
vey were reported within the same four years. DHS data 
are georeferenced which allows for sub-national mapping 
and are thus considered more representative and facili-
tate more extensive potential downstream analyses. The 
maps illustrated the patterns exhibited in the country-
level (Additional file 2) and regional estimates (Table 2). 
Government-based treatment was shown to not be well 
accessed in large parts of SEARO, EMRO, AFRO and 
small patches of PAHO. The map of treatment rates from 
any sector highlighted areas where treatment of was low 
overall.
Discussion
Information regarding the treatment-seeking behaviours 
of fever cases in MECs is essential to assessing the fea-
sibility and success of malaria control and elimination 
programs. Malaria is a treatable disease and while effec-
tive therapies exist, population health-seeking behaviours 
may limit the extent to which they  are utilized. Under-
standing care-seeking rates in MECs also helps to quan-
tify the scale of the malaria burden. Routine surveillance 
data are used to measure the burden of clinical disease 
and only those cases who seek care at a government-
based facility are likely to be included in regional esti-
mates. Quantification of the proportion of cases that are 
severe enough to seek care (clinical), but are missed from 
passive surveillance, is therefore necessary to more accu-
rately estimate ‘true’ case numbers.
Table 2 Weighted means of treatment-seeking rates by WHO region
The most recent treatment-seeking values for all 98 MECs were weighted by size of the population to obtain weighted point, upper and lower estimates
WHO region Government treatment Any treatment
Mean % Upper % Lower % Mean % Upper % Lower %
AFRO-C 45.39 49.14 41.63 63.08 66.76 59.40
AFRO-E 40.26 43.59 36.93 56.29 59.31 53.27
AFRO-S 46.69 50.36 43.04 69.19 72.38 65.94
AFRO-W 48.91 54.52 43.52 59.79 65.12 54.32
EMRO 46.30 57.34 35.86 71.95 79.54 61.10
EURO 52.91 58.76 47.16 56.08 61.90 50.29
PAHO 55.13 61.98 48.59 71.84 77.67 66.05
SEARO 27.62 29.13 26.25 78.83 80.23 77.42
WPRO 54.13 70.52 37.87 71.41 84.02 58.94
Page 8 of 11Battle et al. Malar J  (2016) 15:20 
Data obtained from national surveys (DHS and MICS) 
could be assembled for the majority of the MECs (78 %, 
n = 76). Treatment seeking rates specific to fevers were 
available from all DHS surveys and MICS 5, while only 
cough-based treatment rates were available from the 
earlier MICS surveys. Precedent exists for using care-
seeking for respiratory infection as a proxy for fever 
treatment [14, 25], and this was evidenced by compara-
ble treatment-seeking rates for cough and fever in the 
observed data gathered here (Additional file  1: Figure 
S2). Therefore, all available treatment-seeking data were 
used to inform the model. However, because fever is 
a primary symptom of malaria and because DHS data 
are georeferenced and could be mapped sub-nationally, 
DHS data were given precedence when generating final 
mapped outputs and summary estimates of the data 
gathered. Sub-national predictions and mapping of the 
treatment-seeking outcomes using cluster-level data 
to produce smooth surfaces like those produced by the 
Malaria Atlas Project for prevalence was also explored [2, 
53, 54]. However, there were not sufficient covariate data 
available at smooth resolutions at the time of this analy-
sis to support this. The quantity and quality of higher 
resolution sub-national covariate data that can be used in 
geostatistical analyses continue to improve with time and 
there may be greater potential for this type of analysis in 
the future [55].
Gathering treatment-seeking data for all MECs was 
the primary aim of this analysis, with the intent to also 
show sub-national rates where possible. Data that cor-
responded to the covariate variables identified in the 
literature review of key factors determining treatment 
seeking behaviour were readily available from the World 
Bank and produced models to show that government 
Fig. 3 Observed and predicted treatment-seeking proportions. The observed treatment-seeking values in the regions shown in Fig. 1 are mapped 
along with the national-level predicted values for the proportions seeking a government/public treatment and b any treatment. Treatment-seeking 
rates are shown from red (low access) to blue (high). Dark grey areas are those with no data and light grey regions are at no malaria risk
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treatment-seeking and any treatment-seeking could be 
predicted at the national level from a limited set of covar-
iate variables: year, WHO region, percent of pregnant 
women that receive prenatal care, immunization rates, 
primary education completion rate, GDP growth, and 
national health expenditure (public and total). The per-
centage of women receiving prenatal care was a strong 
indicator of fever treatment-seeking that likely drove the 
low model error values observed. The differing drivers of 
seeking care from either source were evidenced through 
the difference in the best models for each treatment-
seeking outcome. Government-based treatment seeking 
was predicted primarily by other health-seeking indica-
tors such as the childhood immunization (DPT) and pre-
natal care. Access to any treatment, on the other hand, 
was also influenced by country wealth and education. 
Educated individuals in more economically stable coun-
tries are therefore more likely to spend money on health 
care outside of the government system.
From the assembled observed data and modelled miss-
ing data, there emerged geographic patterns in both the 
outcomes and the certainty of the predictions. There were 
areas with low access or use of public treatment facili-
ties in all regions of the malaria-endemic world. Figure 3 
highlights areas such as Central Africa and Indian sub-
continent. Accessing treatment of any kind was inher-
ently higher in all countries because government facilities 
are included in that metric. However, the any treatment 
data revealed that treatment-seeking in some endemic 
areas, such as India, Pakistan and Afghanistan, was 
largely pursued outside the public sector. The CI ranges 
(Fig.  2) show that outcomes were well predicted in the 
Americas, but less so in Asia and least accurate in the 
Eastern Mediterranean countries. This implies that mod-
els and indicator variables were better suited to the Cen-
tral and South American countries. Future predictions 
of this nature may be improved by including additional 
covariates or, following further research into treatment-
seeking indicators, parameters that are tailored to each 
region.
The comparison of the two treatment-seeking out-
comes and the measures of uncertainty provide valuable 
information as countries define control and elimination 
goals. The predicted measurements resulted in the great-
est uncertainty, and signal the need for treatment-seeking 
to be formally assessed in those regions. Most nota-
bly, this data assembly and analysis reveals parts of the 
malaria endemic world where treatment is primarily 
sought outside of government programs. In light of con-
cerns regarding the spread of antimalarial resistance [56, 
57], it is essential for countries to ensure that cases are 
being diagnosed and treated properly using approved 
and legitimate drugs [58]. If treatment is most commonly 
sought outside of government-based facilities, control 
programs must consider how best to monitor treatment 
safety and efficacy as well as numbers of cases presenting 
for treatment.
Conclusion
Information on treatment-seeking behaviours in malaria 
endemic countries can be readily assembled from national 
survey data. Where data on treatment-seeking behav-
iours were not available from national surveys, modelling 
techniques using freely available data were applied to fill 
data gaps. Both the results and methods presented have 
potential application beyond those described here and 
may inform the control and burden of other febrile dis-
eases. However, in this context, data on treatment-seeking 
for fever are essential to understanding the efficacy with 
which malaria cases are treated and detected. Gathering 
and visualizing these data for all MECs, sub-nationally 
when possible, is of use to estimate the burden in areas of 
low endemicity where passive surveillance is the primary 
tool through which cases are monitored. These results will 
facilitate downstream efforts to produce a hybridized bur-
den estimation approach that employs both surveillance-
based and cartographic techniques in an effort to more 
accurately quantify the global burden of falciparum and 
vivax malarias and provide immediate feedback regard-
ing parts of the malaria endemic world where treatment 
for malaria is not readily accessed or is more commonly 
sought beyond the government or control programme 
sectors.
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